Label: REYVOW- lasmiditan tablet

  • NDC Code(s): 0002-0265-04, 0002-0632-04
  • Packager: Eli Lilly and Company
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: CV
  • Marketing Status: Export only

Drug Label Information

Updated August 21, 2020

If you are a consumer or patient please visit this version.

  • PRINCIPAL DISPLAY PANEL

    PACKAGE LABEL - REYVOW 50 mg 4ct carton - FOR EXPORT ONLY

    NDC 0002-0265-04

    4 tablets (1 card of 4 tablets)

    REYVOW™

    (lasmiditan)

    tablets 50 mg

    For oral use.

    Each tablet contains 50 mg of lasmiditan.

    Rx only

    50 mg

    Dispense enclosed Medication Guide to each patient.

    Lilly

    PDP Text – REYVOW 50 mg 8ct carton - FOR EXPORT ONLY
  • PRINCIPAL DISPLAY PANEL

    PACKAGE LABEL - REYVOW 100 mg 4ct carton - FOR EXPORT ONLY

    NDC 0002-0632-04

    4 tablets (1 card of 4 tablets)

    REYVOW™

    (lasmiditan)

    tablets 100 mg

    For oral use.

    Each tablet contains 100 mg of lasmiditan.

    Rx only

    100 mg

    Dispense enclosed Medication Guide to each patient.

    Lilly

    PDP Text – REYVOW 100 mg carton - FOR EXPORT ONLY
  • INGREDIENTS AND APPEARANCE
    REYVOW 
    lasmiditan tablet
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0002-0265
    Route of AdministrationORALDEA ScheduleCV    
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    lasmiditan (UNII: 760I9WM792) (lasmiditan - UNII:760I9WM792) lasmiditan50 mg
    Inactive Ingredients
    Ingredient NameStrength
    Microcrystalline cellulose (UNII: OP1R32D61U)  
    Starch, corn (UNII: O8232NY3SJ)  
    Croscarmellose Sodium (UNII: M28OL1HH48)  
    Sodium Lauryl Sulfate (UNII: 368GB5141J)  
    Magnesium Stearate (UNII: 70097M6I30)  
    Polyvinyl Alcohol, Unspecified (UNII: 532B59J990)  
    Titanium dioxide (UNII: 15FIX9V2JP)  
    Polyethylene Glycol 3350 (UNII: G2M7P15E5P)  
    Talc (UNII: 7SEV7J4R1U)  
    Ferrosoferric Oxide (UNII: XM0M87F357)  
    Product Characteristics
    Colorgray (light gray) Scoreno score
    ShapeOVAL (oval) Size9mm
    FlavorImprint Code L50;4312
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0002-0265-041 in 1 CARTON08/21/2020
    14 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    Export only08/21/2020
    REYVOW 
    lasmiditan tablet
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0002-0632
    Route of AdministrationORALDEA ScheduleCV    
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    lasmiditan (UNII: 760I9WM792) (lasmiditan - UNII:760I9WM792) lasmiditan100 mg
    Inactive Ingredients
    Ingredient NameStrength
    Microcrystalline cellulose (UNII: OP1R32D61U)  
    Starch, corn (UNII: O8232NY3SJ)  
    Croscarmellose Sodium (UNII: M28OL1HH48)  
    Sodium Lauryl Sulfate (UNII: 368GB5141J)  
    Magnesium Stearate (UNII: 70097M6I30)  
    Polyvinyl Alcohol, Unspecified (UNII: 532B59J990)  
    Titanium dioxide (UNII: 15FIX9V2JP)  
    Polyethylene Glycol 3350 (UNII: G2M7P15E5P)  
    Talc (UNII: 7SEV7J4R1U)  
    Ferrosoferric Oxide (UNII: XM0M87F357)  
    Ferric Oxide Red (UNII: 1K09F3G675)  
    Product Characteristics
    Colorpurple (light purple) Scoreno score
    ShapeOVALSize12mm
    FlavorImprint Code L100;4491
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0002-0632-041 in 1 CARTON08/21/2020
    14 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    Export only08/21/2020
    Labeler - Eli Lilly and Company (006421325)